Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.540
+0.010 (0.28%)
Nov 28, 2025, 4:00 PM EST - Market closed
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $302.99 million as of December 1, 2025. Its market cap has decreased by -47.47% in one year.
Market Cap
302.99M
Enterprise Value
131.90M
1-Year Change
-47.47%
Ranking
Category
Stock Price
$3.54
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $302.99M, an increase of 167.23%. That is a compound annual growth rate of 19.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 302.99M | 22.70% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | 328.78M | 189.97% |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |